Hillsdale Investment Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-300
Closed -$5.86K 656
2025
Q2
$5.86K Sell
300
-183,650
-100% -$3.26M ﹤0.01% 589
2025
Q1
$3.27M Buy
183,950
+5,970
+3% +$129K 0.17% 172
2024
Q4
$3.81M Buy
177,980
+41,150
+30% +$1M 0.19% 144
2024
Q3
$4.27M Buy
+136,830
New +$3.4M 0.33% 94
2021
Q4
Sell
-14,100
Closed -$894K 564
2021
Q3
$894K Buy
+14,100
New +$1.07M 0.07% 274

Other funds holding CDNA

Hillsdale Investment Management's CDNA Position: Q3 2025 in Review

Hillsdale Investment Management sold out of CareDx (CDNA) in Q3 2025, closing a stake of 300 shares — an estimated $5.86K sold.

Hillsdale Investment Management first reported a position in CDNA in Q3 2021 and held it in 5 quarters. The position peaked at $4.27M in Q3 2024. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

  • Hillsdale Investment Management reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
  • Hillsdale Investment Management sold 300 CareDx shares in Q3 2025, an estimated $5.86K.
  • Hillsdale Investment Management first reported a position in CareDx in Q3 2021 and held it in 5 quarters.
  • Hillsdale Investment Management's CareDx position peaked at $4.27M in Q3 2024.
  • 187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on Hillsdale Investment Management's 13F filing for Q3 2025, filed 10 Nov 2025.